BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 124271
Published online Oct 15, 2026. doi: 10.4239/wjd.124271
Table 1 Comparison of baseline features of the training and validation cohorts, n (%)/mean ± SD
Characteristic
Training cohort (n = 100)
Validation cohort (n = 43)
t/Z/χ2
P value
Male62 (62.00)28 (65.10)0.1250.723
Age (year)70.28 ± 9.6373.70 ± 10.42-1.8980.060
Diabetes duration (year)10.00 (5.00, 15.00)11.00 (8.00, 15.00)-0.3530.724
Coronary heart disease27 (27.00)9 (20.90)0.5880.443
Cerebral infarction45 (45.00)14 (32.60)1.9210.166
Smoking43 (43.00)22 (51.20)0.8080.369
Drinking35 (35.00)18 (41.90)0.6070.436
Fontaine stage-0.3560.722
II39 (39.00)13 (30.20)
III23 (23.00)15 (34.90)
IV38 (38.00)15 (34.90)
BMI (kg/m2)23.12 ± 3.9822.11 ± 3.401.4650.145
Hb (g/L)122.81 ± 21.83125.79 ± 18.36-0.7840.435
ALB (g/L)38.65 (36.43, 40.78)39.00 (34.30, 40.70)-0.7040.481
ALT (U/L)14.00 (11.25, 22.00)14.00 (12.00, 19.00)-0.6590.510
AST (U/L)16.00 (13.25, 21.75)16.00 (12.00, 19.00)-0.8140.416
TBIL (μmol/L)9.45 (7.13, 13.43)8.92 (6.77, 12.28)-1.0540.292
Scr (μmol/L)75.00 (60.25, 110.23)75.00 (57.00, 91.00)-0.9200.357
FPG (μmol/L)7.05 (5.87, 8.84)6.58 (5.42, 8.31)-1.0720.284
HbA1c (%)7.75 ± 1.597.36 ± 1.571.3560.177
TC (mmol/L)3.93 (3.09, 5.03)3.66 (3.07, 5.06)-0.3960.692
TG (mmol/L)1.31 (0.98, 1.68)1.24 (0.97, 1.94)-0.3500.726
LDL-C (mmol/L)2.57 ± 0.832.66 ± 0.85-0.5380.591
HDL-C (mmol/L)0.96 ± 0.251.03 ± 0.29-1.5920.114
FIB (g/L)4.04 (3.33, 5.24)3.78 (2.94, 4.62)-1.1490.251
D-D (mg/L)0.49 (0.29, 0.84)0.43 (0.23, 0.70)-1.2310.218
hs-CRP (mg/L)2.54 ± 1.252.29 ± 1.111.1690.244
TSP-4 (ng/mL)61.26 ± 29.4664.47 ± 28.34-0.6050.546


Write to the Help Desk